Synthesis and antiplasmodial activity of novel phenanthroline derivatives: An in vivo study

Tahghighi, Azar and Karimi, Safoura and Rafie Parhizgar, Arezoo and Zakeri, Sedigheh (2018) Synthesis and antiplasmodial activity of novel phenanthroline derivatives: An in vivo study. Iranian Journal of Basic Medical Sciences, 21 (2). pp. 202-211.

IJBMS_Volume 21_Issue 2_Pages 202-211.pdf

Download (1MB) | Preview
Official URL:


Objective(s): Due to the rapid increased drug resistance to Plasmodium parasites, an urgent need to achieve new antiplasmodial drugs is felt. Therefore, in this study, the new synthetic phenanthroline derivatives were synthesized with antiplasmodial activity. Materials and Methods: A series of 1,10-phenanthroline derivatives containing amino-alcohol and amino-ether substituents were synthesized via facile procedures, starting with 5,6-epoxy-1,10-phenanthroline. Their antiplasmodial activity was then evaluated using Peter's 4-day suppressive test against Plasmodium berghei-infected mice (ANKA strain). Furthermore, the mean survival time of the mice treated with synthetic compounds was compared with the negative control group. Results: The results demonstrated that the compounds 6-(3-(dibutylamino)propylamino)-5,6-dihydro-1,10-phenanthroline-5-ol (7b) at the dose of 150 mg/kg/day and 4-(1,10-phenanthroline-5-yloxy)-N,N-dipropylbutan-1-amine (8b) at the dose of 15 mg/kg/day have 90.58 and 88.32 suppression, respectively. All synthetic compounds prolonged the mean survival time of treated mice in comparison with negative control groups, indicating the in vivo antiplasmodial activity of these new compounds. Conclusion: The present study is the first attempt to achieve new, effective synthetic compounds based on phenanthroline scaffold with the antiplasmodial activity. However, more research is needed to optimize their antimalarial activity.

Item Type: Article
Subjects: QV pharmacology
Divisions: Journals > Iranian J Basic Medical Sciences
Depositing User: ijbms ijbms
Date Deposited: 25 Jan 2018 15:43
Last Modified: 25 Jan 2018 15:43

Actions (login required)

View Item View Item